Suraksha Diagnostic’s share price opened on the BSE at ₹437 apiece, while it opened on the NSE at ₹438 per share ...
The Suraksha Diagnostics IPO is listing today, December 6. Shares of Suraksha Diagnostics will be available on both the BSE ...
The stock made its debut at Rs 437, registering a decline of 0.90 per cent from the issue price on the BSE. During the day, ...
Shares of Suraksha Diagnostic IPO are set to make their debut on Dalal Street today, Friday, December 6, 2024, after the ...
The recent growth number for the second fiscal quarter, has put a dent on the optimism towards India as experts question what ...
Investors who have bid for Suraksha Diagnostic IPO can check their allotment status online. They can log in to either the BSE ...
Suraksha Diagnostic Ltd's IPO was subscribed 11% on the first day of its debut. While retail investors showcased a stronger ...
Initial public offering of 19,189,330 equity shares of face value of Rs. 2 each of Suraksha Diagnostic Limited (the Company or the Issuer) for cash at a price of Rs. 441 per equity share (including a ...
Suraksha Diagnostic Ltd has successfully raised Rs 254 crore from anchor investors ahead of its IPO launch for public ...
Increasing demand in Alberta for diagnostic imaging such as magnetic resonance imaging (MRI) and computed tomography (CT) scans means more appointments are being made months out, with some ...
Unnecessary care is medical care that offers no value to patients and can in fact be harmful. This could be a prescription drug, diagnostic test or medical procedure that is not needed, does not ...
When making diagnostic decisions, radiologists and other physicians may rely too much on artificial intelligence (AI) when it points out a specific area of interest in an X-ray, according to a study ...